Free Newsletter
The 15 most promising biotech companies
Free newsletter via e-mail
Tools
Every year our sister publication FierceBiotech publishes the Fierce 15, a list of the most promising private biotech companies. This year's report is made up of drug developers who have vision, good science and solid management that have helped them not only suvive but excel in the face of economic challenges. These biotechs boast ground-breaking technologies that are redefining the biotech industry amidst adverse market conditions. Some of the winning innovations include a potentially new generation of anti-bacterials, advancements in oncology treatments, and cutting-edge developments in the stem cell field.
Click here to see the 2009 Fierce 15 winners. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
